An ELISA-based method for detection of rabies virus nucleoprotein-specific antibodies in human antemortem samples
Open Access
- 7 November 2018
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (11) , e0207009
Abstract
Rabies is a fatal encephalitic disease in humans and animals caused by lyssaviruses, most commonly rabies virus (RABV). Human antemortem diagnosis of rabies is a complex process involving multiple sample types and tests for the detection of antibodies, antigen (protein), and nucleic acids (genomic RNA). Serological diagnosis of human rabies includes the detection of either neutralizing or binding antibodies in the cerebrospinal fluid (CSF) or serum samples from unimmunized individuals without prior rabies vaccination or passive immunization with purified immunoglobulins. While neutralizing antibodies are targeted against the surface-expressed glycoprotein (G protein), binding antibodies to viral antigens are predominantly against the nucleoprotein (N protein), although there can be antibodies against all RABV-expressed proteins. To determine N protein-specific antibody responses in the CSF and serum during RABV infection, we developed an enzyme-linked immunosorbent assay (ELISA) with purified recombinant N protein expressed in E. coli. N protein-specific immunoglobulin (Ig) subtypes IgG and IgM were detected in the CSF or serum of previously diagnosed human rabies cases. In addition, anti-N protein seroconversion was demonstrated over the course of illness in individual rabies cases. We compared the N protein ELISA results to those of an indirect fluorescent antibody (IFA) test, the current binding antibody assay used in diagnosis, and show that our ELISA is consistent with the IFA test. Sensitivity and specificity of the N protein ELISA ranged from 78.38–100% and 75.76–96.77% with respect to the IFA results. Our data provide evidence for the use of an N protein ELISA as an additional option for the detection of RABV-specific IgG or IgM antibodies in human CSF or serum specimens.Keywords
This publication has 51 references indexed in Scilit:
- An evaluation of two commercially available ELISAs and one in-house reference laboratory ELISA for the determination of human anti-rabies virus antibodiesJournal of Medical Microbiology, 2009
- Identification of New Rabies Virus Variant in Mexican ImmigrantEmerging Infectious Diseases, 2008
- A Reliable Diagnosis of Human Rabies Based on Analysis of Skin Biopsy SpecimensClinical Infectious Diseases, 2008
- Presence of rabies specific immune complexes in cerebro-spinal fluid can help in ante-mortem diagnosis of human paralytic rabiesJournal of Clinical Virology, 2006
- Antemortem Diagnosis of Human RabiesClinical Infectious Diseases, 2004
- Evidence for a viral superantigen in humansNature, 1992
- Human immune response to rabies nucleocapsid and glycoprotein antigensClinical and Experimental Immunology, 1991
- Immunization of monkeys with rabies ribonucleoprotein (RNP) confers protective immunity against rabiesVaccine, 1991
- Acute rabies death mediated by antibodyNature, 1981
- Use of Hybridoma Monoclonal Antibodies in the Detection of Antigenic Differences Between Rabies and Rabies-related Virus Proteins. I. The Nucleocapsid ProteinJournal of General Virology, 1980